STAGE IA2 LUNG CANCER AJCC V8
Clinical trials for STAGE IA2 LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IA2 LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IA2 LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug stop lung cancer before it starts?
Prevention CompletedThis phase II trial tested whether the immunotherapy drug pembrolizumab (Keytruda) can prevent lung cancer in 45 people with high-risk lung nodules or early-stage non-small cell lung cancer. Participants received pembrolizumab intravenously, and researchers tracked tumor response…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Heart monitor reveals hidden damage from cancer radiation
Knowledge-focused CompletedThis study looked at 24 people with lung or esophageal cancer who received radiation or chemo-radiation near the heart. Participants wore a small heart monitor to catch any heart changes that might otherwise go unnoticed. The goal was to see how often heart problems occur after s…
Matched conditions: STAGE IA2 LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC